SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-130050
Filing Date
2022-04-29
Accepted
2022-04-29 07:04:54
Documents
5
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d235425ddef14a.htm DEF 14A 399357
2 GRAPHIC g235425g17d68.jpg GRAPHIC 40010
3 GRAPHIC g235425g18e68.jpg GRAPHIC 38182
4 GRAPHIC g235425g50c16.jpg GRAPHIC 223470
5 GRAPHIC g235425g51d28.jpg GRAPHIC 230691
  Complete submission text file 0001193125-22-130050.txt   1126943
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41199 | Film No.: 22870076
SIC: 2834 Pharmaceutical Preparations